# Independent update reconciliation and correction receipt

Date: November 8, 2026. Review baselines: `94091207a3bd9e175a256427d864799d806a0000` and delta through `37e74880ab75a2d7149654b1430d328338d4abc2`. Scope: research documentation, retained-source arithmetic and propagation of the recorded owner outcome decision. Independent AI-assisted checks do not constitute human scientific or clinical acceptance.

## Corrections applied

1. Propagated `OWNER_ADJUDICATION_MULTIDIMENSIONAL_OUTCOMES_2026-11-08.md` into the Dartmouth draft, current reconciliation, canonical specification and builder row R03. Preserve all relevant outcome domains together; individual experiments still need primary statistical estimands, multiplicity handling and power. The historical proposal and checker fields remain preserved. The resolved mission decision is not reopened.
2. Corrected the remaining quantitative-summary description of Conderino's colorectal health-maintenance figure from screening-event records to patients with documentation outside standardized diagnosis/procedure codes. The primary empirical memo had already been corrected upstream. Different analytic samples remain explicit; no matched within-person loss fraction or missed-care effect is inferred.
3. Carried BLOODTRACC's overall blood-test-abnormality comparator result into the older summary and Dartmouth read-ahead. Preserve the distinction between the main retrospective hybrid analysis and the sensitivity analysis using tests closer to diagnosis.
4. Added Fritz's 49.3% near-diagnosis first-sign group alongside its 19.3% longer-warning group in the upstream summary. Neither is a population predictive value or an observed effect of earlier intervention.
5. Normalized Chima to its 2025 issue with 2024 early-online chronology and Grancher to its 2026 issue. Legacy discovery keys remain unchanged. Hoopes' existing full citation already uses its 2021 issue.
6. Corrected the S1 ledger's common-19-age-groups statement. Exact retained incidence footnotes state SEER 20 / NPCR 19; the separate CI*Rank footnote states 19 for both. Preserve those contexts and the unresolved actual method/comparability question.

## Independent execution and source checks

- At 9409120, a separate reviewer ran all five added numerical programs and 61 unit tests successfully. These programs check stored published quantities and inference boundaries, not re-estimation of the original adjusted study models.
- At 37e74880, a separate delta reviewer ran 66 unit tests and the comparability contract successfully. The exact retained GitHub artifact 13589404488 from run 42411939810 was downloaded as 2,692,160 bytes with SHA-256 `ddee039ad52fbe27b694e3e64a01d7d5ec2b0e9cb24b535fce47b8434dba727a`.
- The pinned replay verified 18 manifest entries and four original HTML/CSV county rows. A separate regex/Decimal extraction reproduced the 6.0/100,000 late-stage rate difference and 0.3 percentage-point case-share difference. Original source-marker and footnote inspection confirmed the registry lineage distinction and age-group wording issue.
- The root reviewer independently reopened Conderino's publisher PDF and Thompson's CDC-hosted manuscript. SHA-256: Conderino `a56c84bca1511bb3ac81ffbb759e28f135d556937410dbff96db7db2e9122b8c`; Thompson `de7219b7103a054a07cee7c815142da92317d28f6429feb05a27d959b703bdd3`.
- Conderino's Results/Discussion and Table4 support the corrected unit and different-sample caveat. Thompson's internal-validity 12,280/16,257 and regional episode-care 10,659/41,165 are different populations, not interchangeable capture rates.
- BLOODTRACC primary full-text Results confirms the 3.56%/5.03% top-percentile sensitivities, expanded outcome counts and 0.84/0.91 sensitivity-analysis discrimination. These are published validation results, not demonstrated intervention benefit.

## Remaining gates

The acquisition receipt's code revision differs from the artifact workflow revision. Matching the ZIP digest does not resolve that binding. Stage-share unknown-stage conventions, exact source-specific age/stage implementation, geographic causal explanations and local intervention effects remain open. Artifact identifiers and workflow metadata in the replay script are declared constants, not independently authenticated by its parser. Its tests do not adjudicate clinical validity.

Independent rechecks of the RAP arithmetic still leave 9 of 36 published age-table comparisons outside the stated rounding envelope. This is an unresolved reproduction discrepancy, not a finding that the publication is erroneous. PRECISE's receipt denominator and Escaron's source/window reconciliation remain distinct from the trials' primary effect estimates.

The separate external arithmetic checker had two interval-classification defects and a failure-exit defect. The original was preserved; a corrected private copy passes the original values and rejects deliberately overlapping intervals and an incorrect expected value. That correction does not modify the repository's five numerical programs.

Retain W2/W4 as partial and W8 as review received with exceptions open. Acceptance counts require the defined work-package criteria, not a count of passing tests. The Dartmouth briefing remains a review draft.

## Primary literature and reproducible anchors

- Conderino 2022: https://link.springer.com/article/10.1186/s12911-022-01831-8
- Thompson 2020 manuscript: https://stacks.cdc.gov/view/cdc/107376/cdc_107376_DS1.pdf
- Virdee 2026: https://link.springer.com/article/10.1186/s12885-026-16179-9
- Fritz 2023: https://pubmed.ncbi.nlm.nih.gov/37138415/
- Chima 2025 issue: https://pmc.ncbi.nlm.nih.gov/articles/PMC12010534/
- Grancher 2026 issue: https://pubmed.ncbi.nlm.nih.gov/41309226/
- Hoopes 2021 issue: https://pubmed.ncbi.nlm.nih.gov/33377908/
- Artifact workflow: https://github.com/mrterryflood-ui/integrated-implementation-intelligence/actions/runs/42411939810

Reproduce the software checks with `python3 research/fragmentation-harm/validate_contract.py` and `python3 -m unittest discover -s research/fragmentation-harm -p 'test_*.py' -v`. Run `replay_retained_county_archive.py` with the unchanged pinned ZIP using its documented arguments. Preserve exact code revision, source digest, runtime and outputs alongside each run.

## Integration of later work and validator regression fixes

The correction branch incorporates the other agent's subsequent work through `f19291fe47da0d9731831a38b504c12680f74e74`. The only overlapping document was the Dartmouth read-ahead. The resolution retains its newer stakeholder and cross-condition language and the recorded outcome decision, while preserving the comparator, statistical-planning, cost and capacity qualifications.

Independent boundary examples found two defects in the new minimal intelligence validator: numeric zero was rejected as a missing effect, and an unrecognized or incompatible evidence grade could be labeled a validated causal effect. The repair reuses the existing six-grade vocabulary, preserves numeric zero, and restricts that causal label to `verified` or `supported` records with the required metadata. Four regression test methods exercise zero, invalid grades, incompatible grades, a positive control and a missing estimate. They failed against the original validator and pass after the change. These are synthetic metadata tests, not causal validation or authenticated review receipts.

The integrated candidate passes 83 research unit tests and the comparability validator using the commands above. The Python research contract has no new app route, database, authorization, model call or production deployment; web UI/typecheck, tenant/persistence and live field acceptance are outside this patch's execution evidence. This does not waive those gates for a future operational integration. PR 86 remains a review branch, with its exact remote revision and workflow results recorded separately from this source document. The broader scientific exceptions above remain open.
